ATLANTA, June 05, 2024 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Cibus, Inc. ("Cibus" or the "Company") (NASDAQ:CBUS) complied with federal securities laws. On June 4, 2024, Bonitas Research published a report alleging, among other things, that "investors have been duped into believing a promotional management team about an over-hyped technology previously tried, tested, and failed by some of the world's largest seed manufacturers and distributors to provide exit liquidity for early- ...

文章核心观点 - 美国律所Holzer & Holzer正在调查生物技术公司Cibus是否违反了联邦证券法 [1][2] - 根据做空研究机构Bonitas Research的报告,Cibus的管理团队夸大了公司的技术,以为早期投资者创造退出机会 [1] - 该消息公布后,Cibus股价下跌 [1] 公司相关 - Cibus是一家上市的生物技术公司,股票代码为CBUS [1] - 公司遭到做空机构的指控,称投资者被公司管理层的宣传欺骗 [1] - 该技术此前已被全球最大种子制造商和分销商尝试和测试,但失败了 [1] 律所相关 - 律所正在调查Cibus是否违反联邦证券法 [1][2] - 律所鼓励购买过Cibus股票并遭受损失的投资者联系他们,讨论自己的法律权利 [2] - 该律所专注于全国范围内的股东和投资者诉讼,包括集体诉讼和衍生诉讼 [3] - 自2000年成立以来,该律所的律师在为受欺骗的股东追回数亿美元赔偿中发挥了关键作用 [4]

SAN DIEGO, June 05, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today announced its participation in the following June investor events. Stifel Cross Sector Insight Conference, Boston, MA - June 5, 2024: Rory Riggs, Co-Founder, Chief Executive Officer, and Chairman, will host a presentation beginning at 1:50 p.m. ET (10:50 a.m. PT). A live audio webcast of the presentation will be acce ...

SAN DIEGO, June 05, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (Nasdaq: CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today announced its participation in the following June investor events. Stifel Cross Sector Insight Conference, Boston, MA - June 5, 2024: Rory Riggs, Co-Founder, Chief Executive Officer, and Chairman, will host a presentation beginning at 1:50 p.m. ET (10:50 a.m. PT). A live audio webcast of the presentation will be acce ...

BOSTON, June 04, 2024 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Cibus, Inc. (NASDAQ:CBUS) for potential securities law violations. Investors who have lost money in their Cibus investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/cbus. What is this all about? Shares of Cibus fell significantly Tuesday morning after Bonitas Research issued a report alleging that they "found no evidence that Cibus' gene-edi ...

SAN DIEGO, June 04, 2024 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of securities laws by Cibus, Inc. (NASDAQ: CBUS). We are looking into whether the Company or its executives failed to disclose vital information to investors, leading to losses on their investments. If you have purchased Cibus securities and have experienced losses, we encourage you to join our investigation to potentially make claims and recover under federal securities laws. W ...

SAN DIEGO, May 15, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company"), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, applauds the Canadian Food Inspection Agency (CFIA), Animal Feed Division's publication of its updated feed guidelines clarifying requirements for new plant varieties developed using applications of gene editing. The guidelines confirm that CFIA intends to fol ...

SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that Rory Riggs, Co-Founder, Chief Executive Officer, and Chairman, and Peter Beetham, Co-Founder, President, and Chief Operating Officer, will host a presentation at the BMO Global Farm to Market Conference taking place May 15-16, 2024. Presentation details D ...

分组1 - 公司正在从一家以研发为主的公司转型为第一家商业化基因编辑公司,正在将验证过的基因编辑性状授权给种子公司,并获得年度专利费 [9][10][11][12] - 公司的基因编辑技术平台RTDS可以在3年内开发出复杂性状,而传统育种或GMO需要10年以上 [18] - 公司已经在油菜和水稻上开发了商业化RTDS平台,并正在开发小麦和大豆平台 [14][15][17][39][40][47] 分组2 - 公司在油菜上的pod shatter reduction性状已经有10家客户,在水稻上的两种除草剂抗性性状HT1和HT3也已经有4家大型客户 [21][32][33][34][35][36] - 除草剂抗性性状在主要作物如玉米、大豆和油菜中占据95%以上的市场份额,这突出了这类性状的巨大需求 [36] - 公司正在开发的高级性状包括抗白粉病和除草剂抗性HT2,其中HT2有望成为第一个达到1亿亩种植面积的基因编辑性状 [43][44][45][46] 问答环节重要的提问和回答 问题1 **Bobby Burleson 提问** 询问欧盟对基因编辑作物的监管进展情况 [60] **Rory Riggs 和 Peter Beetham 回答** 欧洲议会已经投票支持将基因编辑作物的监管与常规育种相同,这是一个重要的转折点。未来6个月内将完成具体法规的制定,预计2025年初就可以在欧洲开展试验和商业化 [61][62][63][64][65][66][67] 问题2 **Carol Cheung 提问** 询问公司的总可寻址市场规模以及未来2-3年的渗透率 [76][77] **Rory Riggs 和 Peter Beetham 回答** 公司的目标市场非常大,如大豆全球种植面积超过5亿亩,其中仅美国和巴西就有2亿亩。公司将采取谨慎的方式估算可寻址市场规模,并逐步渗透,预计到2028年公司的3大性状将全面商业化 [78][79][80][81][82][83][84][85][86][87][88][89] 问题3 **Steve Byrne 提问** 询问公司如何保护知识产权,以及如何应对种子被保存后再次种植的问题 [90] **Peter Beetham 回答** 公司与客户密切合作,采取多种措施保护知识产权,包括利用杂交种子、强大的专利组合以及与客户的合同条款。同时公司也关注终端销售的专利费用问题,这在大豆、油菜等作物中已有先例 [94][95][96][97][98][99][100][101][102]

Cibus (CBUS) came out with a quarterly loss of $1.12 per share versus the Zacks Consensus Estimate of a loss of $1.01. This compares to loss of $5.45 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -10.89%. A quarter ago, it was expected that this developer and licensor of plant traits for seed companies would post a loss of $1.12 per share when it actually produced a loss of $1.16, delivering a surprise of -3.57%. Over the l ...